An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 302 participants.
Also called NCT02082184
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 302 participants
- Sponsor
- Registry
-
NCT02082184
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- France, Germany, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02082184. Randomized; no masking; primary purpose other. Start 2014-03 (registry gives no type); primary completion 2015-06 (actual). Results posted on 2017-04-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes
- Acronym
- REPLACE
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Device)
- Sensor Based Glucose Monitoring System
- Intervention (Device)
- Standard Blood Glucose Monitoring
- Lead sponsor
- Abbott Diabetes Care
Record details
- Record id
cardio:ct-nct02082184- Content hash
b3dccb8f214d2145d296cbc95caf58b92e7eb9b35e376c3227a2760cc7787a5c